PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.740
-0.090 (-4.92%)
Nov 4, 2024, 4:00 PM EST - Market closed
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
$2,247,667
Market Cap
13.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Psychemedics | 116 |
Aspira Women's Health | 64 |
Evaxion Biotech | 49 |
Sol-Gel Technologies | 36 |
Imunon | 33 |
IN8bio | 31 |
QT Imaging Holdings | 14 |
COSCIENS Biopharma | 12 |
PMCB News
- 5 months ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 5 months ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 1 year ago - PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc. - Business Wire
- 1 year ago - PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology - Business Wire
- 1 year ago - PharmaCyte Biotech Announces Final Results of Tender Offer - Business Wire
- 1 year ago - PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share - Business Wire
- 1 year ago - PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan - Business Wire
- 2 years ago - PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value - GlobeNewsWire